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Abstract
Background: The promise of microbicides as an HIV prevention method will not be realized if
not supported by health care providers. They are the primary source of sexual health information
for potential users, in both the public and private health sectors. Therefore, the aim of this study
was to determine perceptions of vaginal microbicides as a potential HIV prevention method among
health care providers in Durban and Hlabisa, South Africa, using a combination of quantitative and
qualitative methods.
Results: During 2004, semi structured interviews with 149 health care providers were conducted.
Fifty seven percent of hospital managers, 40% of pharmacists and 35% of nurses possessed some
basic knowledge of microbicides, such as the product being used intra-vaginally before sex to
prevent HIV infection. The majority of them were positive about microbicides and were willing to
counsel users regarding potential use. Providers from both public and private sectors felt that an
effective microbicide should be available to all people, regardless of HIV status. Providers felt that
the product should be accessed over-the-counter in pharmacies and in retail stores. They also felt
a need for potential microbicides to be available free of charge, and packaged with clear
instructions. The media was seen by health care providers as being an effective strategy for
promoting microbicides.
Conclusion: Overall, health care providers were very positive about the possible introduction of
an effective microbicide for HIV prevention. The findings generated by this study illustrated the
need for training health care providers prior to making the product accessible, as well as the
importance of addressing the potential barriers to use of the product by women. These are
important concerns in the health care community, and this study also served to educate them for
the day when research becomes reality.
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Background
Evidence from studies of the female condom ([1-5]),
emergency contraception [6], and medical abortion
([7,8]) reminds us of the potent influence that health care
providers' (HCPs') beliefs and attitudes can have on the
promotion of these technologies to potential users (PUs).
In the field of HIV prevention, emerging technologies like
microbicides have the potential to impact public health
significantly, and the role that HCPs play as their patients'
primary source of HIV and STI information will be crucial
in successfully dispensing, educating and providing access
to microbicides, once they become available [9].
Mantell and colleagues (2005) have discussed the intro-
duction of the female condom in the early nineties, draw-
ing the comparison with microbicides as a novel, women
– initiated HIV prevention method [4,10]. The female
condom has not had the impact on reducing HIV trans-
mission that researchers had hoped for, and this is due in
large part to the lack of acceptability research among
HCPs prior to introduction. Most research was conducted
after the female condom had been introduced, and HCPs
were often unprepared to counsel and educate PUs into
making informed choices regarding its use [10]. With the
female condom, a lack of awareness among HCPs regard-
ing design features, cost as well as unfamiliarity with vari-
ous physical characteristics of the product, also
contributed to low acceptability among PUs [10].
Drawing on the lessons learnt from the female condom,
researchers in the field of microbicides are now keenly
aware of the importance of acceptability studies among
HCPs prior to product introduction
Sub-Saharan Africa is bearing the brunt of the HIV pan-
demic, with women accounting for a large part of new
infections. HCPs beliefs and attitudes in sub-Saharan
Africa, as well as the role they play as educators, have been
found to significantly influence PUs acceptance of a prod-
uct [2-4]. Bearing this in mind, as well as the fact that new
HIV infections occur mostly among women in this region,
it becomes critical that researchers investigate HCPs level
of awareness and opinions regarding the promotion of
vaginal microbicides as an HIV prevention method.
HCPs' also play a key role in determining the best chan-
nels for access and distribution of novel HIV prevention
and reproductive health methods[6,8,10,14]. In countries
with high HIV and AIDS prevalence, public sector work-
load and resources are severely strained and may limit
HCPs' ability to promote and market microbicides to PUs'
[14]. Moreover, there has been a dearth of research on the
impact of the health care delivery systems on the adoption
of new disease prevention technologies and the need for
adaptations in service provision. As such, it is not known
how HCPs will cope with the potential introduction of a
microbicide. Therefore, one of the objectives of the
present study was to investigate HCPs opinions regarding
channels for delivery, access and distribution.
This study conducted by the Medical Research Council of
South Africas' HIV Prevention Research Unit (HPRU), rep-
resents the first comprehensive attempt to understand the
views of HCPs with regard to promoting potential micro-
bicides. The participants were not given information on
microbicides prior to data collection by the interviewers.
However, the study was conducted in areas where exten-
sive education was provided to the community at large,
including HCPs
Methods
Ethical approval
Ethical approval was obtained from the University of
KwaZulu-Natal Biomedical Research Ethics Committee
(BREC). Approval was obtained from the KwaZulu-Natal
Provincial Department of Health to approach public hos-
pital staff, whilst private sector health care providers were
approached directly by project staff.
Study population and setting
The study population consisted of 149 HCPs recruited
from 53 clinics and hospitals. The majority of these were
facilities that serviced the public sector (49/53), whilst the
remainder were private hospitals (4/53). Their locations
were in the city of Durban and the rural district of Hlabisa
in KwaZulu-Natal Province, South Africa. All private hos-
pitals were situated in Durban. Since the majority of the
South African population access services through the pub-
lic health service due to economic reasons, the researchers
purposively sampled more HCPs from this sector. Clinics
were randomly selected by health districts using the pro-
vincial Department of Health's list of health care centres.
The 149 HCPs recruited consisted of 14 hospital managers
(HMs), 10 pharmacists and 125 nurses. Participants were
purposively sampled, and more nurses were recruited
since they form the backbone of public sector health serv-
ices. Physicians were not included since they do not inter-
act with PUs to the extent that nurses do. Traditional
healers were also not included in the sampling as the
study was focused on HCPs from the formal health sector.
Pharmacists were included since they are ideally posi-
tioned to increase people's access to microbicides, in
terms of product placement and dispensing. Numerous
clinics are often serviced by a single pharmacist, thereby
accounting for the lower number of pharmacists sampled.
Hospital Managers were recruited so as to obtain views on
access and distribution, as well as capacity building needs
with regard to a potential large-scale microbicide roll-out.
The majority of HCPs were recruited from Durban, sinceAIDS Research and Therapy 2007, 4:7 http://www.aidsrestherapy.com/content/4/1/7
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Hlabisa has a limited public health service sector with
only 20/125 nurses and 1/10 pharmacists being recruited
from the latter area. Refer to Figure 1 that shows the pop-
ulation and setting breakdown.
Data collection and procedures
Data collection for the study took place between February
and November 2004. A semi-structured key informant
interview (SSI) with each HCP was conducted. The SSIs
consisted of both closed and open-ended questions and
were used to obtain individual perspectives from the
HCPs professional position.
Focus Group Discussions (FGDs) were also held with the
Chief Professional Nurses (CPNs) from the local health
authority. All CPNs were sampled to represent clinic areas
in Durban and there were 5 FGDs with between 7 and 12
members per FGD. 90% of the participants were women,
as there are few men in the nursing services in the public
sector. The FGDs were aimed at understanding the group
dynamics that might impact on nurses' attitudes towards
potential microbicides.
At each facility, researchers met with managers and staff to
discuss the project and recruitment strategy. A team mem-
ber described the study purpose, procedures, audio-
recording, confidentiality, and obtained informed con-
sent. Interview appointments were thereafter scheduled
with some HCPs, whilst others were interviewed at the
time of study recruitment.
Semi-structured interviews
The SSI explored four core domains: Section A dealt with
participants' socio-demographic details (gender, area and
type of practice, race, and religious affiliation).
Section B focused on descriptions and opinions about micro-
bicides. This section questioned HCPs on their awareness
Study population and settings Figure 1
Study population and settings.AIDS Research and Therapy 2007, 4:7 http://www.aidsrestherapy.com/content/4/1/7
Page 4 of 13
(page number not for citation purposes)
of microbicides, source, and content of information;
when information was acquired; opinion on its use for
HIV prevention; target groups and age restrictions for pro-
motion; disease prevention effectiveness relative to con-
doms; and intentions to recommend to others.
Section C dealt with barriers to and facilitators of the intro-
duction of microbicides. HCPs were asked about cultural,
political, religious and social; literacy and communica-
tion barriers between researchers and the target commu-
nity; there willingness to counsel clients; challenges in
promoting method in clinics and adequacy of staff
resources.
Section D was concerned with marketing strategies for
microbicides. Questions were asked regarding the most
appropriate media communication channels, opinion
leaders and communication agents, ideal times for pro-
motion, preferred venues for obtaining microbicides,
packaging preferences, and cost.
All HCPs were asked the same questions on demographic
details in section A. For section B, questions were the same
across job strata with a few exceptions:
(a) Nurses and Pharmacists were further questioned on
whether they would recommend microbicides to PUs if
they were 'as effective as condoms' and 'less effective than
condoms'.
(b) The interviewer probed nurses and pharmacists on the
question dealing with a potential microbicide that is 'less
effective than condoms', by asking if they would recom-
mend such a microbicide (i) with or without condoms;
(ii) to be used more often without a condom; (iii) and
alternate between condoms and microbicide.
For section C, questions were tailored to provide informa-
tion on how HMs would deal with obstacles facing their
hospitals, staff and clients, in the event of a large-scale
microbicide roll-out. With pharmacists, questions regard-
ing the challenges of product placement and effective dis-
pensation were emphasized. With nurses, different
questions in this theme were asked to gain insight as to
how they would counsel and educate PUs about using a
potential microbicide, and the challenges that may go
with it.
Section D on marketing strategies asked the same ques-
tions, and was targeted towards pharmacists and nurses
only.
Focus group discussions
The FGDs were conducted among CPNs using questions
similar to the open-ended questions from the SSI ques-
tionnaires. The following questions and themes were
explored:
(a) Information about microbicides.
(b) Microbicides as an STI/HIV prevention method.
(c) Groups of PUs to which the microbicide should be dis-
pensed to.
(d) Factors that affect the dispensation of microbicides in
the health sector.
(e) Preferred marketing strategies in the introduction of
the microbicide to the public.
(f) The most effective strategy to provide information to
the clinic.
(g) If microbicides were introduced in the health care sys-
tem, how would you like them to be introduced in clinics
and hospitals?
(h) How should microbicides be packaged?
(i) Dispensation of the products in the pharmacy.
(j) If microbicides were to be dispensed in stores, where
should it be displayed?
(k) If microbicides were introduced, how would you want
PUs to obtain them?
(l) The acceptability of products to PUs.
Data analysis
Quantitative data from the SSIs were entered into an Epi-
Info™ Version 6.4D database and checked twice prior to
analysis with SPSS™ version 11.5. Data frequencies and
tables were prepared and content analysis of the responses
to the open-ended questions in the SSIs and FGDs was
performed to identify and code salient themes, which
were thereafter analyzed quantitatively using SPSS™ ver-
sion 11.5. During content analysis, new codes emerged
inductively following reading of the data. The codes were
developed independently by research staff, who held
meetings to achieve consensus about the coding catego-
ries and met regularly to resolve discrepancies.
The SSIs and FGDs were conducted by bilingual Zulu-Eng-
lish research staff with experience in conducting qualita-
tive and quantitative interviews. Research staff were
trained by senior study staff. All interviews were audio-
recorded to ensure accuracy and quality of data and were
transcribed verbatim.AIDS Research and Therapy 2007, 4:7 http://www.aidsrestherapy.com/content/4/1/7
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Results
(1) Socio-demographic characteristics of participants
The 149 HCPs consisted of 14 HMs, 10 pharmacists, and
125 nurses. Ninety four percent (140/149) were female
and from the public sector (93%, 138/149), with 78%
(116/149) being of African descent. All of the HMs, 90%
(9/10) of pharmacists and 84% (105/125) of nurses were
from Durban. The remaining single pharmacist and 16%
(20/125) of nurses worked in Hlabisa. Most of the HCPs
(87%) followed the Christian faith.
In terms of type of practice/facility, 57% (71/125) of
nurses worked in primary health care clinics, whilst 28%
(35/125) worked in comprehensive facilities. The remain-
ing 15% (19/125) of nurses were spread between family
planning clinics, sexually transmitted diseases clinics and
the like. For pharmacists, half of them worked in a clinic
environment, whilst the remaining 50% (5/10) worked in
commercial pharmacies. For the HMs, 78% (11/14)
worked in primary health care environments, whilst the
remainder came from other hospital settings.
(2) Health care providers descriptions and opinions about 
microbicides
Description's of microbicides
This aspect of the study was undertaken to assess HCPs
ideas and beliefs about what microbicides were, including
descriptions of physical features and intended purpose.
Fifty-seven percent (8/14) of HMs, 40% (4/10) of phar-
macists and 35% (44/125) of nurses had heard about
microbicides before. Most participants had acquired this
information in the previous year (2003), and primarily
from the HPRU's training and community entry pro-
grammes that are run throughout the province. A broad
and simple definition of microbicides was also provided
on the SSI questionnaire itself as follows:
"A microbicide could be used with the male and female
condom for extra protection. Some people may choose to
use them without condoms. There are many factors that
will impact on women's decisions to use these sub-
stances".
HMs with prior information of microbicides had a vague
understanding of the candidate products, and described
them as a 'cream [that] prevents STIs; a cream [that] prevents
pregnancy; they will kill...microorganisms.' However, some
were able to describe microbicides in more specific terms
– 'can be used as a protection against STDs even AIDS
and...applied in the vagina by an applicator before sexual inter-
course.'
Whilst the 40% (4/10) of pharmacists with prior informa-
tion of microbicides had a better understanding when
compared to HMs, only one pharmacist (1/10) was aware
that the active ingredient in microbicides is still unknown,
given that all the products are currently in the testing
phase.
Nurses who had prior information of microbicides as a
potential HIV prevention method were reasonably accu-
rate in their descriptions of candidate products – 'a
gel...applied by females to prevent sexually transmitted infec-
tions.' One nurse expressed the following unsettling view
about microbicide research: 'The rumour was that they
(researchers)will ask you to sleep with a positive person
(HIV)to prove whether it works.'
Microbicides as a prevention method and empowering tool for 
women
Hospital managers saw potential microbicides as an
empowering tool for women, recognizing that a person
could 'make a decision alone without having to involve the
partner' and that 'men are resisting using condoms'. Pharma-
cists said that they were 'an excellent idea, convenient and
good but not guaranteed to be used without a condom because
a condom is used for more than one purpose, here referring to
the advantage of contraception that condoms have over
potential microbicides, where the latter may or may not
be indicated for contraception. Most nurses recognized
that microbicides potentially could empower women,
'especially in our Black culture' and corroborated the view
that 'males don't want to use condoms'. One nurse supported
microbicides 'as long as [they are] not going to be messy'.
Fifteen nurses were uncertain of their feelings about
potential products. Only four of the 94 nurses who had
prior knowledge about microbicides had negative opin-
ions of them, challenging their potential acceptability and
effectiveness. This was reflected in the following state-
ments:
'If [a]sex worker uses it, how effective is it going to be for her to
carry it in her purse? Cultural beliefs may be a restriction.'
'I don't think it will work or...be acceptable...because I think the
gel is messy'.
'I cannot guarantee it might prevent [HIV]since it's in a gel
form. Gel is usually slippery'.
'Sexual investigations proved HIV not to be manageable. No
hope at all.'
Access to microbicides
Most HCPs (77%) thought that microbicides should be
dispensed to sexually active people whether infected or
not with HIV and other STIs. One hospital manager felt
this way because 'everybody is potentially HIV-positive
until proven otherwise'. One pharmacist thought thatAIDS Research and Therapy 2007, 4:7 http://www.aidsrestherapy.com/content/4/1/7
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since many people do not disclose their HIV status to their
sexual partners, it would be better to give everyone access
to microbicides. Nurses who wanted to dispense the prod-
uct to all people believed that HIV positive people should
have access to microbicides to prevent re-infection,
decrease HIV/STI transmission to others, and prevent the
acquisition of other STIs. For non-infected people, pri-
mary prevention of HIV infection was the rationale
behind the choice.
The remaining 23% of the HCPs felt that only some
groups of people should receive the product when it
becomes available. One HM felt that it could be detrimen-
tal to administer microbicides to those already infected
because: 'if given to HIV-infected, people will have myths and
mistake the product with the cure and start doing anyhow when
it comes to sexual issues', i.e., sexual promiscuity may result.
One pharmacist advocated microbicides for those
infected with STIs – 'A STI patient is a candidate for HIV. If
you do not treat, STIs, increases...chances of...HIV.'
Whilst the majority of HCPs felt that no age restriction
should be implemented when microbicides are intro-
duced, 17% (25/149) of them believed differently. Some
HCPs who supported a no restriction policy felt that ado-
lescents should be targeted because they are 'sexual
[ly]active with more than one partner'. Pharmacists agreed
with promoting microbicides to all people of all ages, pro-
vided that the 'generic composition of the product...is safe' for
all age groups. These HCPs had strong sentiments regard-
ing the issue of HIV and sexual behaviour among young
people :
'HIV [is]not restricted to any particular age'. [HM]
'Cannot put age restriction because even the 12-year-olds are
sexually active'. [HM]
'Sometimes you find a very young boy doing sex with a very
young girl only to find that the condom does not fit this boy'.
[Nurse]
'It [potential microbicide] should be given to anyone willing to
use it'. [Nurse]
The HCPs who supported age restrictions on access (17%)
felt that youth might abuse microbicides and not take fur-
ther precautions to prevent disease transmission. Others
among this group felt that they should be reserved for
adults 'because...you want to encourage abstinence for the
young person'. A pharmacist pointed out that they were 'not
allowed to dispense to minors below 14 years otherwise we need
informed consent.'
Promoting microbicides as a partially effective prevention method, 
and condom use
When asked if they would recommend potential microbi-
cides if proven to be less effective than condoms, 80% (8/
10) of pharmacists and 75% (93/125) of nurses
responded in the affirmative. The majority of these HCPs
believed some disease protection was preferable to none.
Pharmacists indicated they would recommend a microbi-
cide which was less effective relative to a condom because
'safer sex is better than unprotected sex;for the safety of the
female' and because 'a microbicide is not visible', unlike the
female condom. However, most pharmacists stated that
in this case they would prefer to recommend 'both the gel
and condom'. One pharmacist who would not recommend
a microbicide of partial efficacy preferred to 'improve the
product so that it can have the desired effect'. The same phar-
macist did indicate, however, that a cheaper product
which 'may not have the entire effect' may still have to be
recommended. Nurses, even those who responded nega-
tively to the question, endorsed the recommendation of
both methods for 'dual protection'.
Among nurses in Hlabisa, 60% (12/20) reported that they
would not recommend partially effective microbicides,
whilst in Durban 19% (20/105) would not. One reason
for this discrepancy was that half of the nurses in Hlabisa
misunderstood "less effective" as "not effective at all",
despite clarification by the interviewer. This is illustrated
by the following examples:
'It's a waste of time to recommend something ineffective'.
'No point in using something useless'.
When asked if they would recommend microbicides to
their clients if they were as good as condoms in preventing
HIV and STIs, almost all nurses and pharmacists (~ 100%)
were unanimous that they would. Some of the reasons
offered were:
'HIV is a priority these days and is threatening everyone...We
are willing to use the best product that we can get'. [Pharma-
cist]
'Any drug that has positive therapeutic benefit, is a drug of
choice'. [Pharmacist]
'Because our aim is to fight against HIV and STI's'. [Nurse]
While agreeing to recommend them, one nurse noted that
the decision to use them would be left to the client: 'In the
same way that we promote condom usage, we will do the same
to the gel. We will give clients the option to choose'.AIDS Research and Therapy 2007, 4:7 http://www.aidsrestherapy.com/content/4/1/7
Page 7 of 13
(page number not for citation purposes)
Negative perceptions of condoms and the advantages of
microbicides over condoms were cited as further reasons
to recommend potential microbicides of equivalent effi-
cacy as condoms. Concerns about efficacy for pregnancy
prevention, breakage, allergic reactions, and non-use were
reported as impediments to condom use. In fact, 24%
(30/125) of nurses mentioned the disadvantages of con-
doms and that their clients did not want to use them. In
contrast, microbicides were seen as easy to use, providing
an alternative prevention option and enhancing sexual
sensation, as reflected in HCPs' comments below.
'People find it difficult to put on condoms and [it]does not take
time to apply anything into the vagina. A female can do it prior
[to]...sexual intercourse. It provides protection without forcing
the other partner to use a condom.' [Pharmacist]
The one nurse who was against recommending potential
microbicides of equivalent condom efficacy felt that
[she]'can only ask for a person to choose to use either of the
two', i.e., in support of informed client choice.
Spreading the message for microbicide usage
Almost all (99%) of the 149 HCPs verbalised that their
colleagues would be willing to recommend potential
microbicides to clients if proven effective for HIV preven-
tion. One HCP said that 'HIV infection is a problem. We do
discuss our programmes. We evaluate our programmes. We test
people at this clinic. If there are any means that...can be done
to prevent this we should try it'. Another stated that she
wished to 'supply all the information so that the person takes
an informed decision'.
One pharmacist felt that 'a nything to prevent the disease
should be used. HCPs should be more knowledgeable about
these. They need training so that they can spread the word
around'. Two of the 10 pharmacists indicated that 'the cost
factor' was important, microbicides should be 'economical
for clients'. Overall, a great majority of nurses would sup-
port 'anything to prevent the disease because it is a killer and
we see what ...HIV is doing to the patients every day'.
All of the nurses and pharmacists reported that they were
willing to counsel clients about using microbicides for
HIV/STI prevention. Nurses saw counseling as their 'duty'
and 'more effective than just issuing without counseling', i.e.,
dispensing microbicides without providing information
about them. Many nurses pointed out that since they
counseled patients about condoms, they would do the
same with microbicides, encouraging clients to make
'informed choices'. One pharmacist commented: 'The more
knowledgeable people are about medication, the more rationally
it will be dispensed'.
(3) Barriers to and facilitators for the introduction of 
microbicides in the public health setting
Potential barriers
Twenty one percent (3/14) of managers, 70% (7/10) of
pharmacists and 62% (76/125) of nurses anticipated var-
ious barriers to the introduction of microbicides. We clas-
sified types of barriers as political, religious, cultural, level
of literacy, miscommunication between researchers and
community, time, resources, training needs, and other.
Managers were concerned about service providers not
being properly informed about the product, as reflected in
the following statement:
'It means that before the product is introduced they would have
to be informed, given lectures and it is only then that they
(HCPs) may try and promote it'
One manager mentioned specific problems at his health
care centre:
'We do not have an antenatal or post natal facility nor do we
have a family planning clinic'
Presumably, a lack of such facilities would act as an obsta-
cle to microbicide delivery. Other concerns that HMs had
are reflected in these quotes below:
Pharmacists worried about the following issues:
'Tendering government pharmaceutical stores. If you haven't
got the government system, it will delay the process'.
'Prescribers may not want to prescribe if the demand is too
high'.
'A person may never anticipate when he/she is going to have
sex'.
Pharmacists also noted that microbicides might be prob-
lematic for users and partners who prefer inserting intra-
vaginal substances for dry sex.
Among nurses, many indicated that men, especially
among those who are of African descent, would not con-
done women taking control over sexual matters. One
social barrier noted was that 'the public may be skeptical'
about microbicides. Some nurses felt that educating peo-
ple about microbicides would be difficult if they were not
provided with 'enough information'.
Many nurses cited a shortage of staff and limited space as
barriers. 'Nurses' attitude [s]towards microbicides...if...nega-
tive' also was perceived to be an impediment. Cost was
perceived to be a potential barrier, with some participantsAIDS Research and Therapy 2007, 4:7 http://www.aidsrestherapy.com/content/4/1/7
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anticipating that microbicides will cost more than con-
doms.
Nurses were further asked about possible challenges in
promoting microbicides to patients in the clinics. In addi-
tion to cost and limited staff resources, other challenges
noted were limited availability and sustainability of prod-
uct in clinics; potential user embarrassment (e.g., 'It might
be difficult to demonstrate the use of this product'), shyness,
and/or discomfort in using a new method; lack of infor-
mation and knowledge about the product, particularly
regarding effectiveness; cultural myths; beliefs about
product efficacy (e.g., 'The people...thinking that this product
will cure HIV') and male partners' reactions (e.g., 'If we are
giving it to females, we don't know how her partner will react').
However, many nurses did not anticipate any challenges
to microbicide introduction in clinics – and believed 'that
the patients will be happy to have access to this product'.
Resources for distribution
Among nurses and pharmacists, nearly all (97%) felt that
their facilities were properly situated for microbicide dis-
tribution. Those who disagreed were probed regarding
what could be done to improve access – 'Usage of mobile
clinics and Teams (health workers) doing home visits' were
suggested. Among the HM's, 29% (4/14) felt that their
staff would be sufficient to handle the demands of prod-
uct roll-out. To ensure adequate staff resources for this
programme, the common sentiment among managers
was that they would 'have to motivate for more staff from the
department'. One manager felt that 'government should pro-
vide more staff whenever introducing new product [s]' and
that 'enough space to accommodate clients' must be provided.
Hospital managers's were asked how they would intro-
duce the new product to their staff. Most opted for in-serv-
ice training workshops; whilst one manager suggested that
'somebody from the company that deals with the product should
come and train staff'. When asked how they would intro-
duce clients to microbicides, managers recommended
advertising and health education – 'Everybody who comes to
the clinic should be informed'.
Counseling for microbicide use
Nurses and pharmacists were asked to rate how effective
certain groups and venues would be for counseling clients
and promoting a potential microbicide. Ninety percent
(9/10) of pharmacists felt clinics would be highly effec-
tive. When asked about chemists, schools, hospitals and
NGOs, 60% (6/10) of pharmacists thought that these
groups would be highly effective. Forty percent (4/10) of
pharmacists, however, were uncertain about the role tra-
ditional healers could play in counseling. Sixty percent
(75/125) of nurses felt clinics would be a highly effective
or effective venue for counseling users about microbi-
cides, and a similar proportion (57%, 71/125) felt the
same about hospitals.
(4) Marketing strategies for microbicides
Promotion venues
Nurses and pharmacists were asked to rate the effective-
ness of various venues for marketing microbicides, includ-
ing advertising via radio, newspapers, TV, leaflets, posters,
taxi ranks, billboards, and retail outlets. Although most
pharmacists considered all of the abovementioned strate-
gies to be highly effective, they rated leaflets, taxi ranks,
and retail outlets as less effective marketing strategies.
About three-quarters of the nurses rated TV and radio
advertising to be highly effective. Similarly, like the phar-
macists, while each type of advertising was evaluated as
highly effective by some nurses, advertising on billboards,
in taxi ranks and retail outlets was viewed to be the least
effective strategies. Nearly two-fifths (59%) of nurses felt
that TV advertisements promoting microbicides should be
screened during all hours of the day. Forty percent (4/10)
of pharmacists agreed. However, another 40% (4/10) of
the pharmacists and about 22% (28/125) of nurses felt
that the most appropriate time for these promotions
would be in the evenings. In terms of radio advertise-
ments, similar proportions of pharmacists (80%) (8/10)
and 77% (96/125) of nurses agreed that advertisements
on radio promoting microbicides should be screened all
of the time.
Promotion strategies
Nurses and pharmacists were asked how they would want
microbicides to be promoted in hospitals and clinics and
were given the following response options: family plan-
ning programmes, one-to-one counseling by nurses,
advertisements on posters in doctors' rooms, life orienta-
tion programmes by clinics in schools, and leaflets in clin-
ics. Eighty percent (8/10) of pharmacists and 87% (109/
125) of nurses opted for all of the above.
Over-the-counter dispensing in pharmacies and retail stores
As shown in Figure 2, the majority of pharmacists (80%,
8/10) and nurses (51%, 64/125) would like microbicides
to be available over-the-counter. Over-the-counter refers
here to products being placed behind store/pharmacy
counters, separate from being placed on shelves. In order
for the product to be obtained from behind a counter, it
would have to be requested for, whereas product place-
ment on shelves can be anonymously retrieved without
requesting help from any store/pharmacy attendant. Phar-
macists and nurses who preferred over-the-counter dis-
pensing were against doctors' prescriptions due to the
added cost of a consultation fee and the frequent lack of
availability of doctors. In addition, over-the-counter was
preferred for 'counseling purposes – Advice on side effects andAIDS Research and Therapy 2007, 4:7 http://www.aidsrestherapy.com/content/4/1/7
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how to use the product' can be given. One pharmacist had
this to say: 'Maybe...everyone will be too shy to go and get it
although this one seems like an expensive product so maybe
over-the-counter'.
Some nurses opted for doctors to prescribe the product
because they felt that 'the doctor will explain to you how to use
them'. Those who preferred the product to be placed on
the shelves preferred this 'so that people will not be embar-
rassed ...asking for the gel'.
Figure 3 indicates that the majority of HM's, pharmacists
and nurses preferred microbicides to be displayed on the
shelves in retail stores. The HCPs saw this as a way to facil-
itate access to the product and instructions (e.g., 'Because
you can take your time and read the information about it on a
box'); and decrease discomfort (e.g., 'Some people may not
be comfortable being seen and asking about the product.
Shelves are private') One pharmacist suggested that micro-
bicides be displayed 'near the dispensary area' to legitimize
it as being health-related and allow greater privacy.
A nurse who favoured the display of microbicides at the
till thought that 'everybody can... see them when they are
standing in the queue' while another nurse noted that that
a person might be motivated to pick up this product while
they are waiting.
Packaging
HCPs acknowledged that the 'packaging must appeal' to
potential users. Some suggested that microbicides be
packaged in a box, while others preferred tubes for safety
(e.g., 'to prevent it from any other contamination in the atmos-
phere'. Some pharmacists advocated for user information
and instruction leaflets and a clearly demarcated expiry
date. Other pharmacists considered size (e.g., 'pack of tam-
Preferences regarding dispensing of microbicides among pharmacists and nurses Figure 2
Preferences regarding dispensing of microbicides among pharmacists and nurses.AIDS Research and Therapy 2007, 4:7 http://www.aidsrestherapy.com/content/4/1/7
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pons') and, material ('cellophane containers like those used for
cooler boxes...for the protection of the contents'), and environ-
ment-friendly issues.
Nurses also suggested that 'the box should be small and sexy
to fit a pocket or a purse and a moisture-proof container' to
prolong the expiry date.
Cost
Seventy percent (7/10) of the pharmacists and 86% (107/
125) of nurses felt that microbicides should be provided
free-of-charge so that 'all people will have access to them'.
Nurses also indicated that many people were unemployed
and thus would be unable to afford microbicides unless
they were free. The remaining 30% (3/10) of pharmacists
felt that microbicides should be available both free-of-
charge and for a fee – 'It can be both ways. For instance, con-
doms are free in clinics and you can buy them at chemists for
those who can afford [them]'. One nurse who preferred
patients to pay for microbicides was concerned that free
microbicides would 'encourage irresponsible [sexual]behav-
iour'.
HCPs were willing to pay as little as R1 to as much as R50
(about $0.17 to $8.33) for the product. R5 – R20 ($0.80
to $3.33) seemed to be an acceptable amount for most
participants. One pharmacist felt that a free trial period
could be beneficial. Microbicides should be free 'for the
first two years because this is marketing. Scientists must commit
[by]giving to our people. By so doing, they'll be making the
product desirable to the community'.
Discussion
HCPs who were primarily from the public sector serve
most of the country. Therefore, their opinions on micro-
bicides are of immense value. Approximately one third
Preferences regarding the display of microbicides in stores among nurses and pharmacists Figure 3
Preferences regarding the display of microbicides in stores among nurses and pharmacists.AIDS Research and Therapy 2007, 4:7 http://www.aidsrestherapy.com/content/4/1/7
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overall of HCPs were aware of microbicides. However, the
depth of their knowledge varied. Whereas some had a
good understanding of what microbicides are and their
mechanisms of protection, others only knew that such
products are being evaluated in research studies. Most
knowledge of microbicides was acquired recently, indicat-
ing the power of information dissemination through the
MRC and other health professionals, and perhaps mount-
ing support. Given that the first results of phase III trials
for some candidates are expected in late 2008, it is imper-
ative that as many HCPs as possible are educated about
microbicides now so that when available, they will be
familiar with and perhaps more open to the concept. As
front-line providers, they are well-positioned to impart
accurate information to their clients. Since clients often
take HCPs into their confidence, they can play a valuable
role in uncovering and challenging misconceptions about
microbicides, e.g., that microbicide testing will involve
deliberately exposing participants to HIV. Addressing
these speculative myths now will help to build confidence
and trust in the effectiveness of microbicides when they
become available.
It was extremely encouraging that the vast majority of
HCPs were positive about microbicides, and many felt
that they should ideally be used in conjunction with con-
doms. HCPs recognized the advantages that microbicides
would have over condoms, especially for women, and
nurses in particular described the lack of condom use
among their clients.
Nearly four-fifths of all study participants felt that micro-
bicides should be made available to everyone, regardless
of age, HIV status, and history of sexually transmitted
infections. HCPs recognize that they can no longer afford
to restrict HIV prevention methods to certain groups
because the entire population in South Africa is vulnera-
ble, especially since rape and migrant labour contribute to
the spread of HIV and AIDS. Nevertheless, some HCPs
supported the restriction of access to microbicides due to
concern that they would be seen as a "magic bullet" or
cure, thus giving users a false sense of safety and perhaps
license to engage in unprotected sex – an emergent con-
cern with post-exposure prophylaxis [11]. In particular,
restricted access to youth was noted.
The majority of HCPs reported that they would support
microbicides if they are as good as condoms in preventing
HIV transmission, especially because of the advantages
that microbicides have over condoms. HCPs in this study
were primarily concerned with the safety and size of the
product applicator. If they are less effective, most pharma-
cists and nurses reported that they would be more likely
to support microbicides for dual method use, since a par-
tially effective microbicide would still provide another
prevention option for women [12]. A method that is less
effective, but used consistently, may have a greater impact
on reducing infection than a higher-effectiveness method
used less consistently. In fact, mathematical modelling
indicates that a microbicide which is 40% less effective
than condoms, but is used only by 30% of the population,
will save 6 million lives the world over in three years [13].
HCPs should be informed of this fact as consistent use of
future microbicides could be the key to decreasing the
spread of HIV in South Africa.
Nurses, especially those in Hlabisa, demonstrated the sig-
nificant effect that incorrect understanding can have on
the perceptions of a product. A large number of them
understood 'less effective' microbicides to be completely
ineffective and as a result, did not want to recommend
them to their clients. When such a product does become
available, health care workers will need to be sufficiently
trained regarding issues such as partial efficacy to prevent
such errors. HCPs will need adequate information so that
they are equipped to counsel patients in making informed
choices.
The creation and dissemination of messages about micro-
bicides now to HCPs will raise awareness of the potential
of microbicides in reducing women's vulnerability to HIV
and AIDS. In addition, early education will help to instill
positive attitudes so that when an effective product comes
to market, they will be prepared to counsel clients into
using them. Since we anticipate that first-generation
microbicides will likely have lower efficacy than con-
doms, we should begin to design hierarchical prevention
messages for HCPs to incorporate into client counseling,
as well as testing their complexity and appeal.
Overall support for microbicides from HCPs was over-
whelming and correlates with data reported in other stud-
ies [14]. HCPs' dedication and sincere concern came
across clearly in their willingness to counsel clients about
microbicides and recommend the new products to others.
HCPs believed that the challenges facing the introduction
of microbicides are extensive. Fewer HMs than nurses and
pharmacists predicted barriers to the introduction of
microbicides. This is significant because nurses and phar-
macists are the ones who interact with patients and bring
their issues across; therefore, their responses are probably
a more valid reflection than those of the HMs. The obsta-
cles foreseen ranged from cultural and religious beliefs to
practical aspects, such as cost and characteristics of micro-
bicides. Cultural practices are complex issues, and those
such as the preference for dry sex and the importance of
preserving a woman's virginity, will need to be addressed.
The fact that microbicides will be novel was also raised,
indicating that education of potential users will be neces-AIDS Research and Therapy 2007, 4:7 http://www.aidsrestherapy.com/content/4/1/7
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sary even prior to microbicides becoming available.
Although health care facilities may be perceived as ade-
quately prepared to handle the introduction of microbi-
cides, additional staff resources will be required to address
foreseeable shortages. Different health care centres will
have their own challenges in rolling out the product and
these will have to be dealt with on an individual basis. The
relevance of these barriers mentioned by HCPs is that each
challenge has the potential to halt the progress and use of
microbicides. It is imperative, therefore, that plans are
developed to overcome them, before the product is mar-
keted for use.
Nurses and pharmacists were of the opinion that multiple
organizations, such as hospitals, NGOs, other community
organizations, and schools need to play a pivotal role in
educating people about microbicides. Promotion of
microbicides should take all forms. While the media was
favoured as an effective marketing strategy, the written
word was also perceived to be a credible source for deliv-
ering health messages. Thus, both print and non-print
media should be used to publicize microbicides.
Further issues involving marketing revealed that HCPs
favour over-the-counter sales of microbicides at pharma-
cies. This was to prevent added costs of consultation fees
and so that patients will receive some counseling on the
product. Adequate reasons were also provided on the pref-
erence of acquiring the product via a doctor's prescription
or on the shelves. The same was noted for retail in stores
– while the majority supported the display of the product
on the shelves, others wished for them to be sold at the
till. This indicates that multiple points of sale are probably
the best option, but issues such as privacy, counseling and
easy access need to be considered. Participants in a
national US study reported that the ideal microbicide
should be available in pharmacies without prescription
and wanted someone to assist them in how to use the
product (Darroch & Frost, 1999). However, most partici-
pants preferred microbicides to be free-of-charge;
although some were concerned that free products would
be perceived to be of inferior quality, which has been
noted about free distribution of male condoms.
Limitations
There were a number of limitations to the current study.
Firstly, the majority of the study participants were women,
reflecting the gender of most HCPs in South Africa's pub-
lic health sector. Thus, whether male HCPs' beliefs and
attitudes about microbicides differ from those of their
female counterparts cannot be determined in this study.
Study participants were self-selected volunteers, but selec-
tion bias was minimized as only a few of those
approached refused to be interviewed individually or via a
focus group. HCPs' responses to microbicides were based
on hypothetical products, and could differ once an effec-
tive microbicide is identified.
Conclusion
This the first comprehensive study to explore HCPs
knowledge and attitudes regarding microbicides. Our data
illustrates important insights into HCPs' level of aware-
ness and knowledge about microbicides and the potential
challenges to be faced, in the event of their introduction.
Understanding HCPs' preferences for marketing strategies
will be invaluable to prepare microbicides for distribution
and optimize their acceptability, uptake, and continued
use. This information can also assist in short-term strate-
gic planning for the crafting of appropriate prevention
messages and identification of distribution channels and
messengers for information dissemination. No single
approach will be sufficient to reach the diversity of pro-
vider and potential user target audiences.
Even in the absence of an efficacious product, increasing
awareness of microbicides and their potential benefits
and limitations will keep HCPs abreast of the current sta-
tus of microbicide research findings. At the same time,
continual evaluation of HCPs' current concerns, and after
a microbicide is on the market, can correct misconcep-
tions and help to shape positive attitudes and community
norms about the possibility of this new women's HIV pro-
tection product.
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